Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness

NCT01018225 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was cancelled due to lack of enrollment

Conditions

Nocturia

Interventions

DRUG: darifenacin
DRUG: Placebo

Sponsor

Cognitive Research Corporation

Collaborators

[object Object]